绿原酸
化学
免疫印迹
油酸
体内
内分泌学
内科学
减肥
肥胖
生物化学
药理学
生物
医学
食品科学
基因
生物技术
作者
Yanchun Zhong,Yueling Ding,Laiqing Li,Meina Ge,Guang-guo Ban,Hongxia Yang,Jun Dai,Licheng Zhang
出处
期刊:Current Pharmaceutical Biotechnology
[Bentham Science]
日期:2020-03-18
卷期号:21 (11): 1099-1106
被引量:20
标识
DOI:10.2174/1389201021666200318124922
摘要
Background: Chlorogenic Acid (CA) has diverse, recognized health effects. Objective: This study aimed to explore the effects of CA on fat reduction and the underlying mechanism of these effects. Materials and Methods: First, we established a Monosodium Glutamate (MSG)-induced obesity mouse model and subjected the mice to 4 weeks of CA gavage. Then, we established an oleic acidinduced model of human fatty liver in HepG2 cells, and administered a CA intervention to the cells for 48 h. Finally, we used Oil red O staining, biochemical detection kits, RT-PCR and Western blot analysis to evaluate the effects of CA on fat reduction and on related pathways. Results: The CA treatment could reduce fat accumulation in the liver and reduce blood lipid levels. In addition, CA decreased the mRNA and protein levels of peroxisome proliferator-activated receptor gamma, coactivator 1 α (PGC-1α) and Uncoupling Protein 1 (UCP1) in the MSG-induced obesity mouse model and the oleic acid-induced HepG2 cells. Conclusion: Based on the above results, we deduced that CA could reduce body weight and fat deposition in vitro and in vivo and that the mechanism may be related to the PGC-1α/UCP-1 pathway. CA can be developed as a drug to lower blood lipids and to treat obesity.
科研通智能强力驱动
Strongly Powered by AbleSci AI